Latest News

Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Impact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod (BMS-986231)

November 2023

For patients with heart failure and congestion, vasodilation with agents such as cimlanod reduces the response to diuretic agents, which may offset any benefit from acute reductions in cardiac preload and afterload.

View article

Richmond Pharmacology at the Forefront of Groundbreaking Gene-Editing Clinical Trials

November 2023

Richmond Pharmacology proudly announces its pivotal role in a ground breaking gene-editing clinical trial for heart disease.

View article

Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: Impending change, innovations and future challenges.

November 2023

The AHPPI conference unfolded as a dynamic exploration of the ever-evolving landscape of early phase clinical drug development.

View article

Richmond Pharmacology Boosts Snowsfields School Library with STEM Book Donation on World STEM Day 2023

November 2023

Snowsfields School Library has received 50 books about science, technology, engineering and maths (STEM) thanks to a donation from Richmond Pharmacology

View article

A Prospective, Observational Study of Bleeding and Quality of Life in Patients with Glanzmann Thrombasthenia in the United Kingdom: Updated Results

November 2023

New insights from a prospective study on Glanzmann thrombasthenia (GT) have been published in Blood (2023).

View article

A Phase 1/2, First-in-Human, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia

November 2023

Exciting findings from a Phase 1/2 first-in-human study on HMB-001 for Glanzmann thrombasthenia have been published in Blood (2023).

View article

Low data variability

Exceptional ECG generation

Experts in cardiac safety

Our specialist services

News

Stay up to date with the latest activity at Richmond Pharmacology

Impact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod (BMS-986231)

Richmond Pharmacology at the Forefront of Groundbreaking Gene-Editing Clinical Trials

Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: Impending change, innovations and future challenges.

Richmond Pharmacology Boosts Snowsfields School Library with STEM Book Donation on World STEM Day 2023

A Prospective, Observational Study of Bleeding and Quality of Life in Patients with Glanzmann Thrombasthenia in the United Kingdom: Updated Results

A Phase 1/2, First-in-Human, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia

主要メンバー紹介

リッチモンドでのキャリア

動画紹介

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

私たちについて

ナレッジベース

ソーシャルメディア